Celularity Receives Nasdaq Delisting Warning

Ticker: CELUW · Form: 8-K · Filed: Nov 29, 2024 · CIK: 1752828

Sentiment: bearish

Topics: delisting, listing-standards, sec-filing

Related Tickers: CELU

TL;DR

Nasdaq's kicking CELU off the exchange, they're figuring out what to do.

AI Summary

Celularity Inc. received a notice on November 21, 2024, indicating it failed to meet the continued listing rule standards for The Nasdaq Stock Market LLC. The company is currently evaluating the notice and will determine its course of action, which may include appealing the determination.

Why It Matters

Failure to meet listing standards could lead to Celularity's stock being delisted from Nasdaq, significantly impacting its liquidity and investor confidence.

Risk Assessment

Risk Level: high — Receiving a delisting notice from a major stock exchange like Nasdaq poses a significant risk to the company's continued trading and investor confidence.

Key Players & Entities

FAQ

What specific continued listing rule did Celularity Inc. fail to meet?

The filing states that Celularity Inc. received a notice of failure to satisfy a continued listing rule or standard, but does not specify which particular rule was violated.

When did Celularity Inc. receive this notice?

Celularity Inc. received the notice on November 21, 2024.

What are Celularity Inc.'s options after receiving this notice?

Celularity Inc. is evaluating the notice and will determine its course of action, which may include appealing the determination to the Nasdaq Listing Qualifications Panel.

Has Celularity Inc. been delisted yet?

No, the filing indicates a notice of failure to meet listing standards, not an actual delisting. The company is in the process of responding to the notice.

What is the ticker symbol for Celularity Inc.?

The filing does not explicitly state the ticker symbol, but it is commonly known as CELU.

Filing Stats: 692 words · 3 min read · ~2 pages · Grade level 12.2 · Accepted 2024-11-27 21:08:46

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CELULARITY INC. Date: November 29, 2024 By: /s/ Robert J. Hariri Robert J. Hariri, M.D., Ph.D. Chairman and CEO

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing